Discover a new way to find and share stories you'll love… Learn about Reading Desk

All Blogs / Industries / Medical / Popular


Get More Specific:

Predicting Metastasis at MetaStat: Interview with CEO Dr. Oscar Bronsther

Metastasis of cancer cells from the primary tumor represents one of the most serious concerns for any cancer patient and can affect clinical decisions regarding treatment for the disease. The ability to predict the likelihood of metastasis...Show More Summary

Top 10 Science Fiction Movies About the Future of Medicine

As a science fiction movie geek, I collected those 10 movies that give a good picture about what we can expect to see in the next years in the future of medicine. Please share your favorite ones and read more about such movies in “The Guide to the Future of Medicine“. Here are the movies […]

Juno Shares Exploded Post-IPO. Should You Consider Buying Them?

One of the most exciting companies in biotech just had one of the year’s most exciting initial public offerings. Shares of Seattle-based Juno Therapeutics increased 60% from their listing price to $38 in late morning trading in the biggest biotech IPO of the year. The company will have a total market capitalization of $2.85 billion. […]

Nanoplug Hearing Aid to Hide Within Ear Canal (VIDEO)

Hearing aids have come a long way lately, thanks to new audio processing algorithms, miniaturization, and wireless capabilities. Yet, they can still be too large to wear inconspicuously and can get quite pricey. Now a new project raising...Show More Summary

Guest Post: How ‘Noisy’ Data Is Holding Hospitals Back

Asha Saxena is the president and CEO of Future Technologies Inc., an international data management solutions firm. For many patients, all the information physicians collect before every appointment can be a big nuisance. Do physicians...Show More Summary

When going “by the book” hurts patients

I find myself in a unique position. I recently retired as an orthopedic surgeon and my wife and I moved out of my practice area. At the same time, my wife was diagnosed and started treatment for breast cancer. So I got opportunity to interact with the health care system both as a provider and […]

Think Surgical’s TSolution One Hip Replacement System

THINK Surgical (Fremont, CA) won FDA clearance for its TSolution One Surgical System for performing total hip arthroplasties. The system relies on pre-operative CT scans and consists of the TPLAN surgical planning application and the TCAT computer guided mill that prepares the bone cavity and joint surface. Show More Summary

Physicians: Make your online presence a social one

Establishing a digital presence is rapidly becoming a necessity for health care professionals, medical practices, and institutions. Yet something that often gets obscured in the discussion is the fact that at its heart, digital media is about people. Show More Summary

Critique of an Ad Seen in "Modern Pharma Guidance" Magazine

The ad shown on the left is the subject of an FDA/OPDP "untitled letter" (definition), which took aim at a Sunovion professional print ad for seizure med Aptiom. According to the FDA reviewer of the ad: “Although Aptiom may reduce seizure...Show More Summary

#WWBR Week of December 15, 2014

U.S. Corporate Health Exchanges Find No New Blue Chip Clients Caroline Humer for Reuters “While blue chip companies may be taking a wait and see attitude towards HIX for their employees, the broader and much larger mid-market will move more … Read more ›

Merck, Cubist, and Hospira: The Inside

Or as much of the inside as we're likely to have. Thanks to @AndyBiotech on Twitter, here's an SEC document detailing the negotiations between Merck and Cubist. It makes for interesting reading in general - you can see how a deal like...Show More Summary

Weekly Roundup 12.19.14

The holidays have left little time for posting, but here is at least getting in the Weekly Roundup. Hopefully, however, with the respite that is to come, there will be time to build up some editorial content.  In the meantime, … Continue reading ?

How antibiotics are killing us and the new ones can’t come fast enough

I stared down at the tired, deteriorating woman sprawled across a bariatric bed before me. A breathing tube was in her throat while multiple catheters pierced her arms and neck, pouring powerful medications directly into her veins. Among several functions, these infusions would maintain her blood pressure high enough to keep her organs alive. This […]

Pharma: The Year 2014 in Images

These are my favorite images and posts that appeared in Pharma Marketing Blog in 2014 (see embedded slide deck below - you can also view this directly on slideshare here). It was a very interesting year, especially since FDA finally released some long-awaited social media guidance for the pharma industry. Show More Summary

Non convulsive seizure related altered mental status

When patients present with altered mental status of unclear etiology consider this from a recent study: Objectives To identify the prevalence of NCS and other EEG abnormalities in ED patients with AMS… Results Two hundred fifty-nine patients were enrolled (median age: 60, 54% female). Show More Summary

Another Alzheimer's Antibody Goes Down

The clinical failure rate for disease-modifying Alzheimer's therapies remains perfect, unfortunately: a flat 100%. The latest news is from Roche. Their in-licensed amyloid-targeting antibody (gantenerumab, from MorphoSys) came up empty on an interim trial analysis. Show More Summary

Happy Christmas And A Great 2015!

Well, that is your lot for the year unless we have some important news emerge of the 'silly season', that I feel an urgent need to post on. I plan to re-start posting in mid to late Junuary 2015. Till then stay safe and have a great break! David. This is the initial part of the post - read more by clicking on the title of the article. David.

Rethinking IV hydralazine

IV hydralazine is popular in hospitals because it is old, familiar and easy to use. A recent post at Emergency Medicine PharmD serves as a reminder of the potential for adverse effects. Among the downsides are unpredictable pharmacokinetics...Show More Summary

The flu vaccine is imperfect, but please get it anyways

This year’s flu vaccine, as you likely know, is taking a drubbing. The contention is that CDC flubbed, and didn’t get quite the right flu strains in the mix. That is apparently true, although more the “fault” of the influenza virus and its natively wily ways, than of the CDC. Either way, the drubbing is disproportionate to […]

A Holiday Greeting Dance from Drug Channels

Dear Drug Channels reader, Wow. It’s hard to believe that another crazy, busy year is already coming to an end. Thank you for welcoming me into your inboxes and browsers. I’ve had fun writing about 2014’s unexpected, unusual, and fascinating developments. Show More Summary

Copyright © 2011 Regator, LLC